PubMed:33040051
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 475-489 | Body_part | denotes | Interleukin-10 | http://purl.org/sig/ont/fma/fma264825 |
| T2 | 475-486 | Body_part | denotes | Interleukin | http://purl.org/sig/ont/fma/fma86578 |
| T3 | 573-583 | Body_part | denotes | troponin I | http://purl.org/sig/ont/fma/fma62340 |
| T4 | 573-581 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 0-8 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 69-91 | Disease | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0004995 |
| T3 | 137-145 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 172-200 | Disease | denotes | cardiovascular disease (CVD) | http://purl.obolibrary.org/obo/MONDO_0004995 |
| T5 | 748-783 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
| T6 | 754-783 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
| T7 | 1056-1064 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T8 | 1075-1110 | Disease | denotes | Acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
| T9 | 1081-1110 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
| T10 | 1147-1155 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T11 | 1196-1223 | Disease | denotes | acute myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0004781 |
| T12 | 1202-1223 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
| T13 | 1303-1311 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 10-11 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T2 | 93-103 | http://purl.obolibrary.org/obo/BFO_0000030 | denotes | OBJECTIVES |
| T3 | 475-489 | http://purl.obolibrary.org/obo/PR_000001471 | denotes | Interleukin-10 |
| T4 | 588-590 | http://purl.obolibrary.org/obo/CLO_0008426 | denotes | pg |
| T5 | 603-605 | http://purl.obolibrary.org/obo/CLO_0008426 | denotes | pg |
| T6 | 728-729 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T7 | 1028-1029 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-92 | Sentence | denotes | COVID-19: a risk factor for fatal outcomes in patients with comorbid cardiovascular disease. |
| T2 | 93-104 | Sentence | denotes | OBJECTIVES: |
| T3 | 105-201 | Sentence | denotes | To evaluate the fatal impact of COVID-19 on patients with comorbid cardiovascular disease (CVD). |
| T4 | 202-210 | Sentence | denotes | RESULTS: |
| T5 | 211-355 | Sentence | denotes | Overall, the 28-day mortality of patients with comorbid CVD was 3.25 times of that of patients without comorbid CVD (40.63% vs 12.50%, P=0.011). |
| T6 | 356-417 | Sentence | denotes | Clinic symptoms on admission were similar for the two groups. |
| T7 | 418-675 | Sentence | denotes | However, patients with comorbid CVD had higher levels of Interleukin-10 (22.22% vs 0%, P=0.034), procalcitonin (22.6% vs 3.13%, P<0.001), high-sensitivity troponin I (20 pg/mL vs 16.05 pg/mL, P=0.019), and lactic dehydrogenase (437 U/L vs 310 U/L, P=0.015). |
| T8 | 676-891 | Sentence | denotes | In addition, patients with comorbid CVD experienced a high incidence of acute respiratory distress syndrome (59.38% vs 15.63%, P<0.001), and required more invasive mechanical ventilation (40.63% vs 12.50%, P=0.011). |
| T9 | 892-989 | Sentence | denotes | Methylprednisolone was found to improve the survival of patients without comorbid CVD (p = 0.05). |
| T10 | 990-1002 | Sentence | denotes | CONCLUSIONS: |
| T11 | 1003-1074 | Sentence | denotes | Comorbid CVD resulted in a higher mortality rate for COVID-19 patients. |
| T12 | 1075-1224 | Sentence | denotes | Acute respiratory distress syndrome was the primary reason of death for COVID-19 patients with comorbid CVD, followed by acute myocardial infarction. |
| T13 | 1225-1233 | Sentence | denotes | METHODS: |
| T14 | 1234-1367 | Sentence | denotes | This retrospective study used propensity score matching to divide 64 COVID-19 patients into two groups with and without comorbid CVD. |
| T15 | 1368-1476 | Sentence | denotes | Clinic symptoms, laboratory features, treatments, and 28-day mortality were compared between the two groups. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 69-91 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
| T2 | 172-194 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
| T3 | 754-774 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
| T4 | 1081-1101 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
| T5 | 1202-1223 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |